SCIENTIFIC PROGRAMME
SESSION I
BIOLOGY OF B-CELL
PRECURSOR ALL
SESSION II
BIOLOGY OF T-CELL ALL
SESSION III
MINIMAL RESIDUAL
DISEASE MONITORING
SESSION IV
INDIVIDUALIZED
MANAGEMENT OF ALL
SESSION V
NEW ADVANCES IN ALL
SESSION VI
CAR T-CELLS &
ALLOGENEIC HSCT
SESSION VII
FRONTLINE
INCORPORATION OF
BITES AND ADCS
SESSION VIII
T-CELL ALL AND
LYMPHOBLASTIC
LYMPHOMA
SESSION IX
PH AND PH-LIKE ALL
SELECTED ABSTRACTS
FOR AN ORAL
PRESENTATION
SELECTED ABSTRACTS
AS E-POSTERS
DISCLOSURES
ABSTRACTS SELECTED AS E-POSTERS
IN ALPHABETIC ORDER ACCORDING TO THE NAME OF THE FIRST
AUTHOR
BIOLOGY POSTERS
Poster 1: PD-1 EXPRESSION IN PEDIATRIC B-CELL PRECURSOR ACUTE
LYMPHOBLASTIC LEUKEMIA AT DIAGNOSIS AND AFTER INDUCTION
REMISSION TREATMENT
Clara Andrade, Elda Noronha, Bruno de Aguiar Gonçalves, Vinícius Cotta-de-
Almeida, Daniella Mendes-da-Cruz, Maria S. Pombo-de-Oliveira, Eugênia
Terra-Granado
Poster 2: BCR-ABL P190 QUANTITATION EVALUATED BY COMMERCIALLY
AVAILABLE ASSAYS AND THE CEPHEID XPERT® BCR-ABL ULTRA P190
PROTOTYPE‡ASSAY
Adam Aslam, Tran Tran, Vineela Kadiyala, Phat Nguyen, Jessica Dosanjh,
Yuanyuan Liu, Lin Yuan
Poster 3: CDKN2A LOSS-OF-FUNCTION COOPERATES WITH CONSTITUTIVE JAK2
SIGNALING IN ACCELERATING T- AND B-ALL DEVELOPMENT
Telmo A. Catarino, Ivette Pacheco-Leyva, Isabel Silva, Luís Maia, Nuno R. dos
Santos
Poster 4: IMPACT OF TUMOR-ASSOCIATED MYELOID CELL DEPLETION ON T-CELL
LEUKEMIA DEVELOPMENT
Telma Costa, Ivette Pacheco-Leyva, Nuno R. dos Santos
Poster 5: MOLECULAR MECHANISMS INDUCED BY OXIDATIVE STRESS ON THE
TRANSCRIPTIONAL ACTIVITY OF NRF-2 IN LYMPHOID CELLS
Melisa Costilla, Rodrigo Macri Delbono, Alicia Klecha, Mariana Daniela
Kovalovsky, Graciela Cremaschi, María Laura Barreiro Arcos
Poster 6: ACQUIRED MUTATIONS WITHIN THE JAK2 KINASE DOMAIN CONFER
RESISTANCE TO JAK INHIBITORS IN IN VITRO MODELS OF A HIGH-RISK
ACUTE LYMPHOBLASTIC LEUKAEMIA
Charlotte Downes, Barbara J. McClure, John B. Bruning, James Breen,
Jacqueline A. Rehn, David Yeung, Deborah L. White
Poster 7: COMBINED PROTEOMIC AND TRANSCRIPTOMIC APPROACH
IDENTIFIES PTPRC AS A NOVEL TARGET FOR HSA-MIR-363-3P IN T-CELL
ACUTE LYMPHOBLASTIC LEUKEMIA
Monika Drobna-Sledzinska, Natalia Mackowska, Roman Jaksik, Maria
Kosmalska, Lukasz Sedek, Tomasz Szczepanski, Michal Witt, Malgorzata
Dawidowska